Mitotic Spindle Inhibitors

MITOTIC SPINDLE INHIBITORS


MITOTIC SPINDLE INHIBITORS

  • Drug groups included:
    • Vinca alkaloids, taxanes, ixabepilone, eribulin mesylate & estramustine.

1. Vinca alkaloids:

  • Drugs: Vincristine, vinblastine & vinorelbine.
  • Vinca alkaloids result in SIADH.

MOA:

  • Acts by inhibiting polymerization of microtubules→ thus, inhibiting mitotic spindle formation.
  • Effective in M-phase of cell cycle.

Drug effects:

  • Vinblastine – Causes bone marrow suppression.
  • Vincristine – 
    • Marrow sparing
    • Neurotoxic (peripheral neuropathy).

Uses:

  • Curative therapy of metastatic testicular tumors – Mainly Vinblastine.
  • DOC for inducing remission in childhood leukemias – Vincristine with glucocorticoids.
    • Combination also used for pediatric solid tumors (Wilm’s tumor, neuroblastoma, rhabdomyosarcoma) & lymphomas.

2. Taxanes:

  • Drugs: Paclitaxel, docetaxel & cabazitaxel.
  • MOA: Acts by preventing disassembly of microtubules  –> Thus, interfering with mitotic spindle formation.
  • Both drugs cause bone marrow suppression & neurotoxicity.
  • Paclitaxel:
    • Causes hypersensitivity reactions.
    • Due to cremophor-containing vehicle.
    • Protein-bound paclitaxel (nab-paclitaxel) – Decreased risk of hypersensitivity reactions.
  • Drug interactions:
    • Cisplatin decreases paclitaxel clearance.
    • Paclitaxel decreases doxorubicin clearance.
  • Cabazitaxel:
    • A microtubule inhibitor.
    • Indicated in hormone-refractory metastatic prostate cancer – In combination with prednisone.

3. Ixabepilone:

MOA:

  • Acts by binding to tubulin & promoting microtubule stabilization —> Hence, arresting cells in the G2-M phase of cell cycle.
  • New drug approved for treatment of advanced breast carcinoma resistant to anthracyclines and taxanes.
  • Given in combination with capecitabine.

4. Eribulin Mesylate:

  • Microtubule inhibitor.
  • Approved recently for metastatic breast cancer treatment.

5. Estramustine:

  • Combination of estrogen & mechlorethamine (nitrogen mustard).
  • MOA: Acts as anti-mitotic drug by binding to tubulin.
  • Used for prostatic carcinoma treatment.
  • Produce estrogenic side effects (gynaecomastia & impotence).

Exam Important

  • Mitotic spindle inhibitors include Vinca alkaloids, taxanes, ixabepilone, eribulin mesylate & estramustine.
  • Vinca alkaloids result in SIADH.
  • Vinca alkaloids act by inhibiting polymerization of microtubules, thus inhibiting mitotic spindle formation.
  • Vinca alkaloids are effective in M-phase of cell cycle.
  • Vinblastine is mainly used for Curative therapy of metastatic testicular tumors.
  • Vincristine with glucocorticoids is DOC for inducing remission in childhood leukemias.
  • Vincristine is marrow sparing but is neurotoxic (peripheral neuropathy).
  • Paclitaxel causes hypersensitivity reactions, due to cremophor-containing vehicle.
  • Protein-bound paclitaxel (nab-paclitaxel) has decreased risk of hypersensitivity reactions.
  • Cabazitaxel is indicated in hormone-refractory metastatic prostate cancer, in combination with prednisone.
  • Ixabepilone acts by binding to tubulin & promoting microtubule stabilization —> Hence, arresting cells in the G2-M phase of cell cycle.
  • Ixabepilone is a new drug approved for treatment of advanced breast carcinoma resistant to anthracyclines and taxanes.
  • Eribulin Mesylate is a microtubule inhibitor.
  • Estramustine is a combination of estrogen & mechlorethamine (nitrogen mustard).
  • Estramustine acts as an anti-mitotic drug by binding to tubulin.
  • Estramustine is used for prostatic carcinoma treatment.
  • Estramustine produces estrogenic side effects (gynaecomastia & impotence).
Don’t Forget to Solve all the previous Year Question asked on MITOTIC SPINDLE INHIBITORS

Module Below Start Quiz

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this:
Malcare WordPress Security